Udemy Launches New AI Fluency Packages to Accelerate Workforce Transformation
Udemy launches a suite of new AI Packages designed to help organizations and professionals develop AI fluency
Share
'At Udemy, we believe that building the right AI skills, sharpening them over time, and keeping them up to date is the key to driving stronger business performance,' said Hugo Sarrazin, President & CEO at Udemy. 'As AI adoption surges across industries globally, Udemy's dynamic marketplace enables us to respond to technological shifts with unprecedented agility. While traditional publishers struggle to keep pace, our platform can introduce and update cutting-edge AI reskilling/upskilling journeys in real-time, ensuring learners and organizations are equipped with the most relevant skills.'
In today's uncertain global labor market, and with the rapid pace of change in AI, organizations need expert guidance and support to assess their current skills gaps and develop a clear path forward to drive better outcomes. That's exactly what Udemy's new AI Packages are designed to support. Customers can get access to:
The AI Readiness Package for building foundational AI skills. The AI Readiness Package includes 50 curated courses along with a structured introduction to AI concepts. Learners will also have access to the Udemy AI Assistant which provides real-time coaching and in-course support to help the learner better understand the concepts and tools being taught. Additionally, learners can develop real-world soft skills through immersive, instructor-designed conversation simulations with Udemy's AI-powered Role Play.
The AI Growth Package to support teams who want more specialized AI skills. The AI Growth Package is targeted at teams looking to develop advanced, role-specific skills including generative AI for performance and productivity, neural networks for data science and engineering, and agentic AI. It builds on the AI Readiness Package and includes an additional 30+ curated learning paths, multilingual support, and certification prep, along with access to both the Udemy AI Assistant and Udemy AI Skills Mapping, which helps leaders develop personalized and targeted learning paths at scale.
These new packages build on the success of Udemy's standalone AI courses, which have already surpassed 11 million enrollments, and the recently launched 'AI for Business Leaders' program designed to help senior leaders build core AI skills as they guide their teams toward developing an AI habit and, ultimately, AI fluency.
To complement the new offerings and support more advanced use cases, including broader digital transformation initiatives, Udemy continues to offer a comprehensive Enterprise Plan that includes access to 30,000+ premium courses and 200+ certification paths as well as a full suite of Professional Services that gives learning and business leaders access to expert help so that they can develop a fully customized, end-to-end program aligned with business objectives.
With the introduction of these new packages, Udemy continues to expand its suite of AI offerings – spanning both content and platform – delivering on its mission to transform lives through learning and drive AI fluency for organizations and professionals worldwide.
To learn more about Udemy's unique approach to AI upskilling and reskilling, visit https://business.udemy.com/spotlight/ai-upskilling.
About Udemy
Udemy (Nasdaq: UDMY) is an AI-powered skills development platform transforming how companies and individuals across the world build the capabilities needed to thrive in a rapidly evolving workplace. By combining on-demand, multi-language content with real-time innovation, Udemy delivers personalized experiences that empower organizations to scale workforce development and help individuals build the technical, business, and soft skills most relevant to their careers. Today, thousands of companies, including Ericsson, Samsung SDS America, On24, The World Bank, and Volkswagen, rely on Udemy Business for its enterprise solutions to build agile, future-ready teams. Udemy is headquartered in San Francisco, with hubs across the United States, Australia, India, Ireland, Mexico and Türkiye.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
Beeline Holdings Inc (BLNE) Q2 2025 Earnings Call Highlights: Strategic Divestment and Revenue ...
Release Date: August 14, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Beeline Holdings Inc (NASDAQ:BLNE) successfully divested its spirits assets, allowing a full focus on its core digital mortgage lending business. The company reported a 27% increase in revenue and a 40% decrease in expenses in Q2 2025 compared to Q1 2025. Beeline Holdings Inc (NASDAQ:BLNE) introduced a new equity product that is not tied to interest rates, providing a competitive advantage. The AI sales agent, Bob, significantly improved lead conversion and mortgage application rates, contributing approximately $150,000 in revenue. The company reduced its debt by $6.2 million in 2025, aiming to be debt-free by November 1, 2025, and cash flow positive by January 2026. Negative Points The market remains challenging due to higher interest rates affecting refinance and purchase transactions. The company reported a net loss from continuing operations of $4 million for Q2 2025. There were $500,000 in one-time non-recurring expenses in Q2, impacting financial results. The broader launch of the new equity product has been delayed to ensure proper execution and customer satisfaction. Despite improvements, the company still faces significant scaling challenges and uncertainties in its new product offerings. Q & A Highlights Warning! GuruFocus has detected 5 Warning Signs with BLNE. Q: Can you provide more details about the home equity cash-out product and the timing of its broader launch? A: (Nick Lauza, CEO) We initially planned to launch in late August or early September but decided to delay to ensure we get it right. The opportunity is massive, with untapped equity in the US market. The Genius Act provides regulatory clarity, and we want to ensure the product is perfect before scaling. We will conduct a select number of transactions over the next 30 to 45 days to gather feedback and ensure consumer interests are prioritized. Q: What are the assumptions behind your profitability projections for late this year or early next year? A: (Nick Lauza, CEO) We are focusing on achieving profitability quickly by cutting $225,000 in monthly recurring expenses, which will be fully realized by September. Our locks are up, and we've reduced our marketing budget by $40,000 monthly while maintaining strong performance. We also had $500,000 in one-time expenses in Q2, which won't recur. We aim to be debt-free by November 1 and cash flow positive by January 2026. Q: Can you explain the economics of the fractional products and the expected volume at scale? A: (Nick Lauza, CEO) Our margins will be higher than our mortgage products, with less work involved since we're underwriting the property, not the consumer. We expect about 33% more revenue per file. Marketing expenses will be minimal as our partner will drive the business. We've identified about 1,000 potential customers who would qualify for this product. Q: What will drive significant growth in 2026, even without rate cuts? A: (Nick Lauza, CEO) We expect strong demand for Beeline Equity, as it provides liquidity based on home equity rather than individual qualifications. This product is ideal for those who can't qualify for cash-out refis or HELOCs. Additionally, our mortgage business is improving, and we have a strong title business team. We anticipate the equity product to be our largest revenue generator in 2026, followed by the mortgage and title businesses. Q: Do you have a sensitivity analysis for how rate cuts could impact growth? A: (Nick Lauza, CEO) While we don't have specific figures, a 25 basis point cut would significantly impact our business as a centralized digital lender. Digital models perform better in low-rate environments, and a 1-point cut would lead to rapid growth. (Chris Moe, CFO) Additionally, the longer rates remain high, the more significant the impact of a cut due to pent-up demand. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
11 minutes ago
- Yahoo
Dare Bioscience Inc (DARE) Q2 2025 Earnings Call Highlights: Strategic Advances and Financial ...
Release Date: August 14, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Dare Bioscience Inc (NASDAQ:DARE) is on track to launch its sildenafil cream, Dare to Play, through a 503b outsourcing facility in Q4 2025, marking a significant milestone in women's sexual health. The company is advancing a differentiated clinical pipeline with grant-funded programs targeting unmet needs in contraception, HPV, and preterm birth. Dare Bioscience Inc (NASDAQ:DARE) received positive feedback from its direct-to-patient awareness campaign, highlighting significant interest in its products. The Oviprine Phase 3 trial continues as planned with no new safety concerns, supporting its potential as a hormone-free contraceptive option. The company strengthened its financial position with $17.6 million in net proceeds from stock sales and a $6 million grant payment, enhancing its ability to execute its strategy. Negative Points Dare Bioscience Inc (NASDAQ:DARE) ended the quarter with a working capital deficit of approximately $12.6 million. The company experienced a 71% decrease in R&D expenses compared to Q2 2024, primarily due to reductions in manufacturing and development costs. There were technical difficulties during the earnings call, preventing a Q&A session, which may have limited investor engagement. The company's dual path strategy involves risks associated with FDA approval processes and market acceptance of its products. Despite the progress, the company operates in a highly competitive market with significant challenges in bringing new women's health solutions to market. Q & A Highlights Warning! GuruFocus has detected 3 Warning Signs with DARE. Q: What is the status of the Dare to Play Sildenafil Cream launch? A: Sabrina Martucci Johnson, President and CEO, stated that Dare Bioscience remains on track to support the commercial availability of Dare to Play Sildenafil Cream through a 503b outsourcing facility in the fourth quarter of 2025. This launch is a significant milestone for the company and the field of women's sexual health. Q: Can you provide an update on the Ovaprine Phase 3 trial? A: Sabrina Martucci Johnson explained that the Independent Data and Safety Monitoring Board reviewed interim data from the Phase 3 study and recommended that the trial continue as planned. The interim pregnancy rate was consistent with expectations, supporting Ovaprine's potential as a non-hormonal contraceptive option. Q: What is the dual commercialization pathway for DARE HRT1? A: Sabrina Martucci Johnson highlighted that DARE HRT1, an intravaginal ring for hormone therapy, is pursuing both FDA approval and a 503b compounding opportunity. This approach aims to accelerate patient access while generating necessary data for FDA approval. Q: How is Dare Bioscience expanding into consumer health products? A: Sabrina Martucci Johnson announced plans to launch two non-prescription vaginal probiotics to support vaginal microbiome health. These products will complement the prescription offerings and diversify the company's commercial platform. Q: What are the financial highlights for the second quarter of 2025? A: Marty Herringlayton, Chief Accounting Officer, reported that Dare Bioscience ended the quarter with approximately $5 million in cash and a working capital deficit of $12.6 million. Post-quarter, the company received $17.6 million from stock sales and a $6 million grant, strengthening its balance sheet. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
11 minutes ago
- Yahoo
ClearSign Technologies Corp (CLIR) Q2 2025 Earnings Call Highlights: Revenue Growth and ...
Release Date: August 14, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points ClearSign Technologies Corp (NASDAQ:CLIR) reported a significant year-over-year increase in revenues for Q2 2025, driven by spare parts orders and a boiler burner sale. The company achieved a reduction in net loss by approximately $200,000 compared to the same period in 2024, primarily due to decreased research and development expenses. ClearSign Technologies Corp (NASDAQ:CLIR) successfully reduced its net cash used in operations by approximately $1 million year-over-year, attributed to customer cash collections. The company has a strong cash position with approximately $12.3 million in cash and cash equivalents as of June 30, 2025. ClearSign Technologies Corp (NASDAQ:CLIR) is actively working on significant projects, including two large process burner orders for major refiners and chemical companies, which are expected to drive future revenue. Negative Points Despite the progress, there is a perceived lack of news and order announcements, leading to concerns about the company's progress. The company has experienced delays in project timelines, affecting the start-up of significant installations. Board transitions and resignations have occurred, although the company states there is no cause for concern. There is uncertainty in the market due to factors like tariffs and environmental regulations, which may delay orders. The company is still in the process of expanding its market presence and product offerings, which may take time to materialize into significant revenue. Q & A Highlights Warning! GuruFocus has detected 3 Warning Signs with CLIR. Q: There have been recent announcements about board transitions. Is this a cause for concern? A: Jim Deller, CEO: No, it's not a concern. The board has been reconstituted with new members who are energized to help ClearSign grow. The changes have been significant, but I am pleased with the current board situation and looking forward to the future. Q: The company has been quiet in terms of news. Can you explain what's been happening behind the scenes? A: Jim Deller, CEO: Despite the lack of order announcements, significant work has been ongoing. We have two large process burner orders for major refiners and chemical companies. One project in California is about to start up, and another for a Gulf Coast Chemical Company is moving into the manufacturing phase. We expect these to drive revenue this year. Q: Can you provide more details about the recent advanced engineering order announcement? A: Jim Deller, CEO: The announcement on August 7th was for engineering work to enhance our burner technology. This order allows us to develop new technology and solve a customer's problem, which also helps us bring new technology to market. Q: What is the status of the Department of Energy hydrogen burner development project? A: Jim Deller, CEO: The project is in its final stages, with new burners designed and in manufacture. These burners will be demonstrated in the coming months, and we've received significant industry interest, with discussions for witness testing underway. Q: How is the relationship with Zeco progressing, and what are their motivations for working with ClearSign? A: Jim Deller, CEO: Zeco is a global combustion equipment company, and our partnership extends their product line into low NOx levels. This collaboration is financially beneficial for both parties and helps put ClearSign on the map for a larger audience. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.
